New Market Study Published: Investigation Report on China Rituximab Market ... ClickPress (press release) [ClickPress, Mon Mar 17 2014] Rituximab (trade names "MabThera" by Roche, "Rituxan" by Genetech) is a chimeric monoclonal antibody against the protein CD20 approved in 1997 to treat tumor. It is very effective and shows good tolerance in the treatment ... |
